These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27197674)

  • 1. Direct Comparison of Metastasis-Related miRNAs Expression Levels in Circulating Tumor Cells, Corresponding Plasma, and Primary Tumors of Breast Cancer Patients.
    Markou A; Zavridou M; Sourvinou I; Yousef G; Kounelis S; Malamos N; Georgoulias V; Lianidou E
    Clin Chem; 2016 Jul; 62(7):1002-11. PubMed ID: 27197674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
    Alunni-Fabbroni M; Majunke L; Trapp EK; Tzschaschel M; Mahner S; Fasching PA; Fehm T; Schneeweiss A; Beck T; Lorenz R; Friedl TWP; Janni W; Rack B;
    BMC Cancer; 2018 Feb; 18(1):141. PubMed ID: 29409452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer.
    Tan W; Liang G; Xie X; Jiang W; Tan L; Sanders AJ; Liu Z; Ling Y; Zhong W; Tian Z; Lin W; Gong C
    Oncologist; 2019 Nov; 24(11):e1044-e1054. PubMed ID: 31300482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.
    Sieuwerts AM; Mostert B; Bolt-de Vries J; Peeters D; de Jongh FE; Stouthard JM; Dirix LY; van Dam PA; Van Galen A; de Weerd V; Kraan J; van der Spoel P; Ramírez-Moreno R; van Deurzen CH; Smid M; Yu JX; Jiang J; Wang Y; Gratama JW; Sleijfer S; Foekens JA; Martens JW
    Clin Cancer Res; 2011 Jun; 17(11):3600-18. PubMed ID: 21505063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.
    van Schooneveld E; Wouters MC; Van der Auwera I; Peeters DJ; Wildiers H; Van Dam PA; Vergote I; Vermeulen PB; Dirix LY; Van Laere SJ
    Breast Cancer Res; 2012 Feb; 14(1):R34. PubMed ID: 22353773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.
    Estevão-Pereira H; Lobo J; Salta S; Amorim M; Lopes P; Cantante M; Reis B; Antunes L; Castro F; Palma de Sousa S; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
    J Transl Med; 2019 Dec; 17(1):435. PubMed ID: 31888645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
    Matamala N; Vargas MT; González-Cámpora R; Miñambres R; Arias JI; Menéndez P; Andrés-León E; Gómez-López G; Yanowsky K; Calvete-Candenas J; Inglada-Pérez L; Martínez-Delgado B; Benítez J
    Clin Chem; 2015 Aug; 61(8):1098-106. PubMed ID: 26056355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer.
    Madhavan D; Zucknick M; Wallwiener M; Cuk K; Modugno C; Scharpff M; Schott S; Heil J; Turchinovich A; Yang R; Benner A; Riethdorf S; Trumpp A; Sohn C; Pantel K; Schneeweiss A; Burwinkel B
    Clin Cancer Res; 2012 Nov; 18(21):5972-82. PubMed ID: 22952344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
    Qattan A; Intabli H; Alkhayal W; Eltabache C; Tweigieri T; Amer SB
    BMC Cancer; 2017 Nov; 17(1):799. PubMed ID: 29183284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response Assessment With Molecular Characterization of Circulating Tumor Cells and Plasma MicroRNA Profiling in Patients With Locally Advanced Breast Cancer During Neoadjuvant Chemotherapy.
    Akkiprik M; Koca S; Uğurlu MÜ; Ekren R; Peker Eyüboğlu İ; Alan Ö; Erzik C; Güllü Amuran G; Telli TA; Güllüoğlu MB; Sezerman U; Yumuk PF
    Clin Breast Cancer; 2020 Aug; 20(4):332-343.e3. PubMed ID: 32201164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer metastasis suppressor-1 promoter methylation in primary breast tumors and corresponding circulating tumor cells.
    Chimonidou M; Kallergi G; Georgoulias V; Welch DR; Lianidou ES
    Mol Cancer Res; 2013 Oct; 11(10):1248-57. PubMed ID: 23744981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-146a Regulates Migration and Invasion by Targeting NRP2 in Circulating-Tumor Cell Mimicking Suspension Cells.
    Do Y; Cho JG; Park JY; Oh S; Park D; Yoo KH; Lee MS; Kwon BS; Kim J; Yang Y
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33396906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients.
    Kumar S; Keerthana R; Pazhanimuthu A; Perumal P
    Indian J Biochem Biophys; 2013 Jun; 50(3):210-4. PubMed ID: 23898484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of metastasis-related microRNAs in early breast cancer patients with a long follow-up.
    Markou A; Yousef GM; Stathopoulos E; Georgoulias V; Lianidou E
    Clin Chem; 2014 Jan; 60(1):197-205. PubMed ID: 24132943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiles of circulating tumor cells versus primary tumors in metastatic breast cancer.
    Onstenk W; Sieuwerts AM; Weekhout M; Mostert B; Reijm EA; van Deurzen CH; Bolt-de Vries JB; Peeters DJ; Hamberg P; Seynaeve C; Jager A; de Jongh FE; Smid M; Dirix LY; Kehrer DF; van Galen A; Ramirez-Moreno R; Kraan J; Van M; Gratama JW; Martens JW; Foekens JA; Sleijfer S
    Cancer Lett; 2015 Jun; 362(1):36-44. PubMed ID: 25797316
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Mastoraki S; Strati A; Tzanikou E; Chimonidou M; Politaki E; Voutsina A; Psyrri A; Georgoulias V; Lianidou E
    Clin Cancer Res; 2018 Mar; 24(6):1500-1510. PubMed ID: 29284708
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
    Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer.
    Papadaki C; Stratigos M; Markakis G; Spiliotaki M; Mastrostamatis G; Nikolaou C; Mavroudis D; Agelaki S
    Breast Cancer Res; 2018 Jul; 20(1):72. PubMed ID: 29996899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer.
    Zhang G; Zhang W; Li B; Stringer-Reasor E; Chu C; Sun L; Bae S; Chen D; Wei S; Jiao K; Yang WH; Cui R; Liu R; Wang L
    Breast Cancer Res; 2017 Jun; 19(1):73. PubMed ID: 28637482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of miR-21 with Circulating Tumor Cells Markers Improve Diagnostic Specificity of Metastatic Breast Cancer.
    Yang X; Wang X; Shen H; Deng R; Xue K
    Cell Biochem Biophys; 2015 Sep; 73(1):87-91. PubMed ID: 25669446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.